<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04770519</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-P00036313</org_study_id>
    <nct_id>NCT04770519</nct_id>
  </id_info>
  <brief_title>Genetic Studies of Strabismus and Associated Disorders</brief_title>
  <official_title>Genetic Studies of Strabismus and Associated Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Strabismus (misalignment of the eyes) often runs in families. In this study, the&#xD;
      investigators are looking for genetic variants in families in which multiple people have&#xD;
      strabismus. Families with at least 3 members with strabismus will be enrolled, and whole&#xD;
      genome sequencing will be used to identify genetic variants shared by family members with&#xD;
      strabismus.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 3, 2021</start_date>
  <completion_date type="Anticipated">December 2026</completion_date>
  <primary_completion_date type="Anticipated">December 2026</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Family-Based</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Genetic variants</measure>
    <time_frame>2 years</time_frame>
    <description>genetic variants shared by family members with strabismus</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Strabismus</condition>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>whole genome sequencing</intervention_name>
    <description>Whole genome sequencing will be performed for all enrolled participants.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All willing members of families in which 3 or more biological relatives have strabismus&#xD;
        (esotropia, exotropia, or vertical misalignments) with full eye movements.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: Member of a family with at least 3 biological relatives with&#xD;
        strabismus. (Both affected and non-affected family members will be enrolled).&#xD;
&#xD;
        -&#xD;
&#xD;
        Exclusion Criteria: paralytic strabismus in affected family members&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mary Whitman, MD/PhD</last_name>
    <phone>617-919-2562</phone>
    <email>mary.whitman@childrens.harvard.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Boston Children's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Whitman, MD/PhD</last_name>
      <email>mary.whitman@childrens.harvard.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>February 23, 2021</study_first_submitted>
  <study_first_submitted_qc>February 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 25, 2021</study_first_posted>
  <last_update_submitted>September 3, 2021</last_update_submitted>
  <last_update_submitted_qc>September 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Boston Children's Hospital</investigator_affiliation>
    <investigator_full_name>Mary Whitman</investigator_full_name>
    <investigator_title>Assistant Professor of Ophthalmology</investigator_title>
  </responsible_party>
  <keyword>strabismus</keyword>
  <keyword>esotropia</keyword>
  <keyword>exotropia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Strabismus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>De-identified genetic data will be deposited in dbGAP (database of genotypes and phenotypes) after publication.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

